Newer Iron Formulations That Reduce Side Effect

Newer iron formulations such as bisglycinate, liposomal iron, sucrosomial iron, ferric maltol, and modern IV iron may offer better tolerability and fewer gastrointestinal side effects than traditional iron salts.

Written by Aisha Saleem, Pharmacist & Health Writer at PharmaHealths.com

Last Updated: August 20, 2026

Ferrous sulfate isn’t your only option anymore, and if it’s the reason you’ve stopped taking iron before, that’s genuinely worth knowing.

I still see ferrous sulfate handed out as the automatic first choice for iron deficiency,
mostly because it’s cheap and well-studied.

But it’s also the formulation most likely to leave someone constipated, nauseated, or simply done with treatment altogether. Several newer options exist specifically to solve that problem, and they’re not experimental anymore, they’re backed by real clinical evidence. In practice, this is often where patients begin to notice a real difference in tolerability.

Key Statistics on Newer Iron Formulations

Traditional oral iron salts like ferrous sulfate carry a discontinuation or non-compliance rate as high as 30 to 40% due to gastrointestinal side effects, according to a clinician’s guide on oral iron published by the Society for the Advancement of Blood Management. That’s a significant portion of patients who never actually complete treatment long enough to correct their deficiency.

Ferrous bisglycinate, one of the newer chelated forms, achieves comparable or superior increases in ferritin and hemoglobin compared with ferrous sulfate, often at a substantially lower elemental iron dose, with significantly fewer gastrointestinal side effects, according to a comparison published by Superpower. This matters clinically because a formulation someone can actually tolerate long enough to finish treatment tends to outperform a theoretically stronger one that gets abandoned after a week. That trade off matters more than it initially seems.

Ferrous Bisglycinate: Iron Bound to an Amino Acid

This is often the first alternative I suggest when a patient has struggled with standard iron tablets.

Ferrous bisglycinate is a chelated form of iron, meaning the iron is bound to two molecules of glycine, an amino acid your body already recognizes and absorbs through its own dedicated pathway. Because of this different absorption route, ferrous bisglycinate exposes the stomach and intestinal lining to far less free, reactive iron than ferrous sulfate does, which is largely why it causes noticeably less nausea, constipation, and cramping. It’s also effective at meaningfully lower doses, typically 10 to 25 milligrams of elemental iron, compared with the 60 to 100 milligrams often used with ferrous sulfate. The main drawback is cost, since bisglycinate formulations generally run three to five times more expensive than standard ferrous sulfate tablets. For many patients, though, better tolerance often justifies the higher cost.

Liposomal Iron: Iron Wrapped in a Protective Shell

Liposomal iron takes a different approach entirely, and it’s one of the more interesting developments in oral iron in recent years.

In this formulation, iron is encapsulated within a phospholipid bilayer, essentially a microscopic fat-based shell, which allows it to pass through the digestive tract without directly contacting and irritating the stomach and intestinal lining the way unprotected iron does. In simpler terms, it minimizes direct irritation to the gut. Several studies report near-complete elimination of the gastrointestinal side effects typically associated with iron supplementation. That said, the evidence isn’t uniformly glowing. A 2024 study in the journal Nutrients looking specifically at liposomal iron in patients with non-dialysis chronic kidney disease found only partial correction of iron markers and no significant improvement in hemoglobin, a reminder that even well tolerated formulations don’t automatically work equally well in every population.

Sucrosomial Iron and Ferric Maltol: Options Built for Complex Cases

Two other newer formulations were specifically developed with harder to treat populations in mind.

Sucrosomial iron consists of ferric pyrophosphate protected within a matrix of phospholipids and sucrose esters, absorbed through a distinct pathway in the gut that allows it to partially bypass hepcidin, the hormone that normally blocks further iron absorption after a dose. This makes it a particularly useful option for people with inflammatory bowel disease or chronic kidney disease, conditions where hepcidin tends to run persistently high. This is exactly where standard iron often struggles. Ferric maltol, sold under the brand name Feraccru in several markets, was rationally designed from the ground up to optimize both absorption and tolerability, and it’s been specifically studied and approved for use in adults with iron deficiency related to inflammatory bowel disease.

Both formulations have shown meaningful increases in hemoglobin in clinical trials, according to a review in Haematologica, and a head-to-head trial comparing the two directly in women with iron deficiency anemia is currently recruiting participants as of this writing.

Iron Polysaccharide Complex: Granules Used in Pregnancy

This is another oral option worth knowing, especially if you’ve been handed a small sachet of granules rather than a tablet.

Iron polysaccharide complex binds iron to a carbohydrate chain instead of using a simple salt like ferrous sulfate, and it’s commonly dispensed as fine granules meant to be dissolved or dispersed rather than swallowed whole. In a direct comparison in pregnant women, only 16% of those on iron polymaltose complex reported side effects, compared with 43% on ferrous sulfate, according to a study published in the Archives of Clinical and Medical Case Reports. This is exactly why doctors often reach for the granule form in pregnancy, when nausea is already common and sticking with treatment matters more than raw speed. Hemoglobin improvement was similar between both forms over three months in that study, so the tolerability advantage doesn’t come at the cost of effectiveness. Consistency here matters more than speed.

When Oral Iron Isn’t Enough: Modern IV Iron Options

For some people, no oral formulation, however gentle, is going to be the right answer, and that’s where intravenous iron comes in.

Modern IV iron formulations, including ferric carboxymaltose, ferric derisomaltose, and ferumoxytol, represent a significant improvement over older IV iron products that carried a real risk of serious reactions. These newer options can deliver a full therapeutic iron dose in a single infusion lasting roughly 15 to 60 minutes, with an excellent safety profile according to a review from the American Society of Hematology. IV iron is generally reserved for people with severe deficiency, an inability to tolerate any oral formulation, certain chronic conditions like advanced kidney disease, or situations where correcting iron levels quickly matters clinically, such as before surgery. Mild infusion reactions can occur but typically resolve without treatment, and severe reactions are genuinely rare with these newer formulations. For the right patient, this can be a highly efficient option.

Is a Newer Formulation Actually Worth Switching To?

This depends entirely on your situation, and it’s not a one size fits all answer.

If you tolerate ferrous sulfate without issue, there’s little clinical reason to pay significantly more for a newer formulation, since standard iron salts remain effective and well-studied. But if side effects have caused you to stop treatment before, or you’re managing a condition like IBD or CKD where standard iron tends to perform worse, a conversation with your prescriber about switching formulations is genuinely worth having. In real-world practice, tolerability often determines success more than theoretical potency. I cover the practical side of managing side effects on standard iron first in my article on [iron supplement side effects and how to manage them], which is often worth trying before jumping straight to a more expensive option.

Conclusion

Ferrous sulfate remains a reasonable, well-studied starting point for many people, but it’s genuinely no longer the only option if it hasn’t worked for you. Ferrous bisglycinate, liposomal iron, sucrosomial iron, ferric maltol, and modern IV formulations all offer real alternatives, each suited to slightly different situations.

Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or switching any iron supplementation.

References

• Society for the Advancement of Blood Management, Clinician’s Guide to Oral Iron — https://sabm.org/wp-content/uploads/2026/03/IC3-1-Oral-Iron.pdf

• Superpower, Iron Bisglycinate vs Ferrous Sulfate: Which Is Better? — https://superpower.com/guides/iron-supplements/iron-bisglycinate-vs-ferrous-sulfate

• American Society of Hematology, IV Iron Formulations and Use in Adults, Hematology ASH Education Program — https://ashpublications.org/hematology/article/2023/1/622/506478/IV-iron-formulations-and-use-in-adults

• Nutrients, Efficacy and Safety of Oral Supplementation with Liposomal Iron in Non-Dialysis Chronic Kidney Disease Patients with Iron Deficiency — https://doaj.org/article/d13ea96bfeda4c00a6d2b1da0cd66cd5

• Haematologica, Oral Iron Supplementation: New Formulations, Old Questions — https://haematologica.org/article/view/haematol.2024.284967

• Archives of Clinical and Medical Case Reports, Comparison of the Prophylactic Use of Iron Polymaltose Complex and Ferrous Sulfate in Pregnant Women — https://jag.journalagent.com/z4/download_fulltext.asp?pdir=achmedj&plng=eng&un=ACHMJ-36855

Call To Action

If side effects have made it hard to stick with iron treatment in the past, I’d encourage bringing up these newer formulations with your prescriber rather than assuming ferrous sulfate is your only choice. You can find more on managing side effects with standard iron in my other articles on PharmaHealths.com.

Share your love
Aisha Saleem
Aisha Saleem

Aisha Saleem is a pharmacist and health writer specializing in clinical pharmacology, metabolic health, nutrition, and evidence-based health education. She founded PharmaHealths to provide accurate, reliable, and easy-to-understand medical information for patients and everyday readers. Her content focuses on medications, disease awareness, wellness, and preventive healthcare using trusted scientific sources.

Articles: 426

Leave a Reply

Your email address will not be published. Required fields are marked *